drugset / Trial / NCT00823745

Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

NCT00823745

Phase 1 Completed 7 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is a phase 1 study to assess the routes of elimination of a single oral dose of \[14C\] PF-00868554 and to characterize the metabolic profile following single dose administration.

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Filibuvir Small molecule Oral